HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aikaterini Lalatsa Selected Research

butenafine (Mentax)

1/2021Nanoemulsified Butenafine for Enhanced Performance against Experimental Cutaneous Leishmaniasis.
7/2019Repurposing Butenafine as An Oral Nanomedicine for Visceral Leishmaniasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Aikaterini Lalatsa Research Topics

Disease

4Visceral Leishmaniasis (Kala Azar)
01/2021 - 02/2015
3Cutaneous Leishmaniasis
01/2021 - 10/2020
3Brain Diseases (Brain Disorder)
01/2015 - 06/2012
2Candidiasis (Moniliasis)
08/2019 - 02/2015
1Infections
08/2022
1Hypertension (High Blood Pressure)
09/2021
1Hypotension (Low Blood Pressure)
09/2021
1Malaria
10/2020
1Parasitic Diseases (Parasitic Disease)
10/2020
1Infectious Skin Diseases
10/2020
1Alzheimer Disease (Alzheimer's Disease)
09/2020
1Rheumatoid Arthritis
01/2020
1Skin Diseases (Skin Disease)
01/2020
1Hyperpigmentation
04/2019
1Communicable Diseases (Infectious Diseases)
01/2018
1Neglected Diseases
07/2017
1Trypanosomiasis
01/2017
1Parasitemia
01/2017
1Chagas Disease (American Trypanosomiasis)
01/2017
1Aspergillosis
02/2015
1Neoplasms (Cancer)
01/2015
1Acromegaly
01/2015
1Stroke (Strokes)
04/2014
1Mental Disorders (Mental Disorder)
04/2014
1Pain (Aches)
04/2014
1Brain Neoplasms (Brain Tumor)
04/2014

Drug/Important Bio-Agent (IBA)

6Pharmaceutical PreparationsIBA
09/2021 - 04/2014
4Amphotericin B (Amphotericin)FDA LinkGeneric
10/2020 - 02/2015
3Peptides (Polypeptides)IBA
01/2015 - 04/2013
2ChitosanIBA
08/2022 - 02/2015
2butenafine (Mentax)FDA Link
01/2021 - 07/2019
2buparvaquoneIBA
10/2020 - 01/2018
2HydrogelsIBA
10/2020 - 01/2015
2LipidsIBA
10/2020 - 01/2018
2Excipients (Suspending Agents)IBA
07/2017 - 01/2017
1TabletsIBA
09/2021
1Dosage Forms (Dosage Form)IBA
09/2021
1polyethylene glycol polyethyleneimine nanogelIBA
01/2021
1ChloridesIBA
01/2021
1LipopeptidesIBA
09/2020
1Proteins (Proteins, Gene)FDA Link
09/2020
1Liposomes (Liposome)IBA
01/2020
1sinomenineIBA
01/2020
1ApigeninIBA
01/2020
1Insulin (Novolin)FDA Link
01/2020
1Ketoprofen (Orudis)FDA LinkGeneric
01/2020
1Miconazole (Monistat)FDA LinkGeneric
08/2019
1Clotrimazole (Lotrimin)FDA LinkGeneric
08/2019
1hydroquinone (Esoterica)FDA Link
04/2019
1Antiparasitic Agents (Antiparasitics)IBA
01/2018
1methylamphotericin B (AME)IBA
01/2017
1N-acetoacetyl-N-deacetylcolchicineIBA
01/2017
1Biocompatible Materials (Biomaterials)IBA
01/2015
1lanreotide (Somatuline)FDA Link
01/2015
1Biological ProductsIBA
01/2015
1NeuropeptidesIBA
06/2012

Therapy/Procedure

4Therapeutics
10/2020 - 04/2013
1Oral Administration
01/2017